Assessment of humoral and cell-mediated immunity againstBordetella pertussisin adolescent, adult, and senior subjects in Italy
- 16 January 2008
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 136 (11) , 1576-1584
- https://doi.org/10.1017/s0950268807000192
Abstract
Humoral and cell-mediated immunity (CMI) against B. pertussis was assessed in a sample of adolescent, adult and senior subjects distributed in five different geographical areas in Italy. Most (99·1%) subjects had IgG anti-pertussis toxin (PT) antibodies exceeding the minimum detection level [⩾2 ELISA units (EU)/ml]. There were no significant differences between the genders; 6·2% samples recorded titres ⩾100 EU/ml. CMI was positive [stimulation index (SI) ⩾5] against PT in 39·0% of all samples. This study suggests that B. pertussis continues to circulate in age groups that have been previously considered to be uninvolved in the circulation of this pathogen and that adolescent and adult pertussis boosters may be of value in these populations. Nevertheless, over the last 10 years, large increases in vaccination coverage rates have contributed to reduce the spread of the aetiological agent, especially in the immunized population.Keywords
This publication has 48 references indexed in Scilit:
- What is new in pertussis?European Journal of Pediatrics, 2007
- Immunity to Pertussis 5 Years after Booster Immunization during AdolescenceClinical Infectious Diseases, 2007
- The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis InfectionPediatrics, 2005
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005
- The seroepidemiology of Bordetella pertussis infection in Western EuropeEpidemiology and Infection, 2004
- Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT StudyThe Journal of Infectious Diseases, 2004
- Evaluation of Strategies for Use of Acellular Pertussis Vaccine in Adolescents and Adults: A Cost-Benefit AnalysisClinical Infectious Diseases, 2004
- Sero epidemiology ofBordetella pertussis immune responses in a healthy population in northern GreeceJournal of Clinical Laboratory Analysis, 2004
- Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for considerationVaccine, 2001
- Seroepidemiology of Pertussis in ItalyClinical Infectious Diseases, 1991